Presentation at LSI USa

At LSI USA, Solaris Endovascular’s CEO, Randy Hubbell, shared the company’s mission, milestones, and outlook for the future. The presentation highlighted progress in the Phase II study of Solaris DE—the first and only self-expanding covered stent with sirolimus eluting from the metal edges—now with over 50 patients enrolled. The company also shared updates on Solaris SX, its drug-free base platform, which is currently available outside the United States. Plans for U.S. registration for both products are actively underway.